Detalhe da pesquisa
1.
Uncertainty directed factorial clinical trials.
Biostatistics
; 2024 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38330084
2.
Inference in response-adaptive clinical trials when the enrolled population varies over time.
Biometrics
; 79(1): 381-393, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34674228
3.
Looking ahead in early-phase trial design to improve the drug development process: examples in oncology.
BMC Med Res Methodol
; 23(1): 151, 2023 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37386450
4.
A validation of models for prediction of pathogenic variants in mismatch repair genes.
Genet Med
; 24(10): 2155-2166, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35997715
5.
A Bayesian Multi-Outcome Analysis of Fine Particulate Matter and Cardiorespiratory Hospitalizations.
Epidemiology
; 33(2): 176-184, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35104259
6.
Integration of survival data from multiple studies.
Biometrics
; 78(4): 1365-1376, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34190337
7.
Approximating the Operating Characteristics of Bayesian Uncertainty Directed Trial Designs.
J Stat Plan Inference
; 221: 90-99, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37711732
8.
Leveraging external data in the design and analysis of clinical trials in neuro-oncology.
Lancet Oncol
; 22(10): e456-e465, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34592195
9.
Prospective Study Testing a Simplified Paclitaxel Premedication Regimen in Patients with Early Breast Cancer.
Oncologist
; 26(11): 927-933, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34472667
10.
Oncotype DX testing in node-positive breast cancer strongly impacts chemotherapy use at a comprehensive cancer center.
Breast Cancer Res Treat
; 185(1): 215-227, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32939592
11.
Optimality of testing procedures for survival data in the nonproportional hazards setting.
Biometrics
; 77(2): 587-598, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32535892
12.
A phase II study of cabozantinib alone or in combination with trastuzumab in breast cancer patients with brain metastases.
Breast Cancer Res Treat
; 179(1): 113-123, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31541381
13.
Efficient computation of the joint probability of multiple inherited risk alleles from pedigree data.
Genet Epidemiol
; 42(6): 528-538, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29943416
14.
Adding experimental arms to platform clinical trials: randomization procedures and interim analyses.
Biostatistics
; 19(2): 199-215, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29036330
15.
Prognostic role of circulating exosomal miRNAs in multiple myeloma.
Blood
; 129(17): 2429-2436, 2017 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28213378
16.
Multi-study factor analysis.
Biometrics
; 75(1): 337-346, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30289163
17.
Frequentist operating characteristics of Bayesian optimal designs via simulation.
Stat Med
; 38(21): 4026-4039, 2019 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31215685
18.
Phase I/II trial of the CXCR4 inhibitor plerixafor in combination with bortezomib as a chemosensitization strategy in relapsed/refractory multiple myeloma.
Am J Hematol
; 94(11): 1244-1253, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31456261
19.
A phase 2 study of modified lenalidomide, bortezomib and dexamethasone in transplant-ineligible multiple myeloma.
Br J Haematol
; 182(2): 222-230, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29740809
20.
Comment: Advancing Clinical Trials with Novel Designs and Implementations.
Stat Sci
; 38(2): 216-218, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37654478